Princess Margaret Hospital
Early Cancer Detection in Li-Fraumeni Syndrome Patients Enabled by Liquid Biopsy Test
Integrated analysis of cell-free DNA appears to help predict the development of cancer in individuals with the hereditary cancer susceptibility condition.
Princess Margaret Cancer Centre, Inivata Partner on Clinical Liquid Biopsy Studies
Inivata's InVisionFirst-Lung and RaDaR assays will support studies of the use of liquid biopsies in early and minimal residual disease detection.
The method, called HPV-Seq, detected ctDNA with high sensitivity and specificity, and could help hone precision treatments of HPV-related cancers.
Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round
The Toronto-based company will use the funding to commercialize its cell-free DNA methylation sequencing technology as an early cancer detection test.
Researchers Aim to Improve Lynch Syndrome Testing With Genetic-Epigenetic Combination Method
Premium
The sequencing test involves a single library preparation that is then split for parallel analysis of promoter methylation, MSI calculation, and gene mutation detection.